Patent Oppositions in vaccines and immunity drugs industry

Explore the competitive field of vaccines and immunity drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in vaccines and immunity drugs technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the vaccines and immunity drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the vaccines and immunity drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jul 9, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Neutralization Of Inhibitory Pathways In LymphocytesINNATE PHARMAMay 13, 2026STRAWMAN
Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such CompositionsHRINGMay 13, 2026LABORATORIOS HIPRA
Methods For Treating Nasal Polyposis By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGYMay 6, 2026ENGELHARD
A Novel Method For Stabilization Of A Biopharmaceutical Drug Product During ProcessingLEUKOCAREMay 5, 2026MAIWALD
Nemolizumab In The Treatment Of Atopic Dermatitis With Moderate To Severe ExcoriationCHUGAI SEIYAKU KABUSHIKI KAISHAApr 30, 2026CABINET BECKER ET ASSOCIES
Stable Antibody FormulationREGENERON PHARMACEUTICALSApr 23, 2026STRAWMAN
Compositions And Methods For Muscle Regeneration Using Prostaglandin E2THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITYApr 22, 2026DORRIES
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHEApr 16, 2026STORZ
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHEApr 8, 2026BRAND MURRAY FULLER
High Concentration Anti-Ass Protofibril Antibody Formulations And Methods Of Use ThereofEISAI R&D MANAGEMENTApr 1, 2026WUESTHOFF & WUESTHOFF

To stay ahead in the competitive vaccines and immunity drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the vaccines and immunity drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jul 9, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Feb 17, 2021Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of CancerLUDWIG MAXIMILIANS UNIVERSITT MNCHEN11
Feb 17, 2021Pharmaceutical Composition For Cancer TreatmentOSAKA UNIVERSITY11
Jan 13, 2021Method Of Treating Cancer Using Immune Checkpoint InhibitorBRISTOL MYERS SQUIBB11
Feb 7, 2024Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorREGENERON PHARMACEUTICALS10
May 15, 2019Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHE9
Sep 11, 2019Binding Molecules For Bcma And Cd3AMGEN RESEARCH MUNICH8
May 1, 2019Combination Of Vaccination And Inhibition Of The Pd-1 PathwayCUREVAC8
Jan 3, 2024Method For Producing Rna CompositionsCUREVAC MANUFACTURING8
Feb 26, 2020Toxicity Management For Anti-Tumor Activity Of CarsTHE CHILDRENS HOSPITAL OF PHILADELPHIA8
Oct 27, 2021Use Of Anti-Pd-1 Antibody In The Treatment Of Patients With Colorectal CancerBRISTOL MYERS SQUIBB8